web analytics
-0.5 C
Munich
Wednesday, January 26, 2022

Auxly Cannabis Group Inc. (TSX.V: XLY) Breaks Out

Auxly Cannabis Group Inc (OTCMKTS: CBWTF) is one of the biggest cannabis producers in the world that has not seen the type of recognition of say Aphria or Canopy. The stock has quickly attracted a large shareholder base who believes this one goes way higher.

Auxly Cannabis is quickly establishing itself as a major player in the booming cannabis space responsible for many, many huge recent winners. The sector is on fire as we near legal recreational cannabis in Canada on October 17. The global legal marijuana market is expected to reach USD 146.4 billion by end of 2025, according to a new report by Grand View Research, Inc.

Auxly Cannabis Group Inc. (TSX.V: XLY) (OTCQX: CBWTF) is a vertically integrated cannabis company currently sitting on a war chest of $295 million. The Company’s vision is to become the first and foremost streaming enterprise in the cannabis industry and to provide alternative financing solutions for smaller licensed producers. Auxly is the brainchild of Chuck Rifici – ‘Godfather of Canadian weed’ founder of Canopy Growth, former CEO of Tweed Marijuana Inc, and former CFO of the Liberal Party of Canada. Chuck did a great AMA recently on reddit you can find it here. Auxly currently has licensing and streaming deals with at least 15 licensed producers listed here. Looking at the production numbers Auxly is well on their way to being one of the biggest cannabis producers on the planet.

Auxly is well positioned itself to become a leader in the booming CBD space. On Sept. 28th, the United States Justice Department, through its Drug Enforcement Administration Agency, issued a final order removing cannabidiol from their Schedule 1 list of illegal drugs. Cannabidiol—CBD—is a cannabis compound that has significant medical benefits, but does not make people feel “stoned” and can actually counteract the psychoactivity of THC. The fact that CBD-rich cannabis is non-psychoactive or less psychoactive than THC-dominant strains makes it an appealing option for patients looking for relief from inflammation, pain, anxiety, psychosis, seizures, spasms, and other conditions without disconcerting feelings of lethargy or dysphoria.

Auxly holds an 80% ownership of Inverell S.A., a company based in Uruguay with potentially the world’s largest cannabidiol production capacity and genetic databank of related hemp strains. The Company’s subsidiary Dosecann has already secured an import export license for international markets.

Inverell gives Auxly a diversified source of low-cost CBD production for the Company’s international distribution channels. It also gives Auxly a foothold in the Uruguays cannabis market which aims to be a dominate player globally. Chuck Rifici commented “Uruguay wants to be a cannabis leader so I’m really excited about the long term prospects for Uruguay as a center for production of all cannabanoids at incredibly low cost for export internationally. I think that will be a key piece of our platform as the years unfold.

To Find out the inside Scoop on Auxly Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

In September Auxly announced a strategic investment and commercial rights agreement with Kaneh Bosm. The Transaction provides Auxly access to a significant and established portfolio of international cannabis licenses, assets and distribution networks. As a result of the Transaction, Auxley believes that it has substantially accelerated its entry into numerous international cannabis markets and partnered with an ambitious team focused on future growth. As part of the transaction, Kaneh Bosm changed its name to ICC International Cannabis Corp.

Kaneh Bosm, through its subsidiaries, has a number of agreements and licenses in place related to pharmaceutical distribution, wholesale importation, research and development, cultivation, production, storage, and exportation of cannabis and cannabis derivatives. In particular, Kaneh Bosm has agreements in place to supply a European-based pharmaceutical distributor with a network of 35,000 pharmacies in 16 countries, in addition to working interests in industrial hemp licenses in Greece and wholly-owned licenses to cultivate, produce, distribute, store, and export cannabis in Colombia, the Kingdom of Lesotho, and Denmark. In addition, Kaneh Bosm is actively pursuing further cannabis licenses and related infrastructure in other international jurisdictions where cannabis is legal for medical or non-medical purposes. Kaneh Bosm intends to use the net proceeds from the Investment to begin its growth and development under the strategic alliance with Auxly, as well as for working capital and general corporate purposes.

Earlier this year Auxly acquired Dosecann Inc. a late-stage “Licensed Dealer” applicant pursuant to the Narcotic Control Regulations. Located in the biotech hub of Charlottetown, Prince Edward Island, Dosecann is currently completing the buildout of a 42,000 square foot facility, purpose-built for the research, development, extraction, formulation, filling and packaging of cannabis-based products.

We have a Monster Pick Coming. Subscribe Right Now!

Currently trading at a $506 million market valuation Auxly is sitting on a war chest of $295 million, and is debt free. Led by cannabis visionary Chuck Rifici, Auxly has quickly attracted a leadership team of industry first movers, enterprising visionaries and deep-experience specialists. Auxly has licensing and streaming deals in place with at least 15 licensed producers and is well on their way to being one of the biggest cannabis producers on the planet.We will be updating on Auxly when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with Auxly.

Sign Up now for our 100% FREE Penny Stock Newsletter

Disclosure: we hold no position in Auxly either long or short and we have not been compensated for this article.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.